Biologics targeting interleukin (IL)-12, IL-23, and IL-17 may have valuable safety benefits among older adults with psoriatic disease, as a lower rate of serious infection was observed among these ...

The FDA has approved Dupixent for the treatment of patients aged 12 years and older with CSU who remain symptomatic despite H1 antihistamine treatment.

Neonatal herpes simplex virus can be fatal and is disproportionately common in the US among infants born in the South and to Black parents.

Women with relatively low oral health scores were more likely to suffer migraine headaches and higher body pain scores.

A White House internal memo listed intended HHS budget cuts in addition to ongoing layoffs, particularly for the CDC and NIH.

Icotrokinra appears to be an effective treatment for adolescents with moderate to severe plaque psoriasis, according to a subgroup analysis of the ICONIC-LEAD study.

Kevin Hall resigned from the NIH and accused the HHS of censoring his research findings on ultra-processed foods.

The FDA will begin promoting computer-based and lab-grown drug testing models to reduce the cost, time, and ethical burden of drug testing.

Several factors are associated with increased mortality in patients with bullous pemphigoid, with mortality rates increasing 5 years after diagnosis.

Several dermoscopic findings may help identify low-grade dysplastic nevi from other lesions, though the performance of the methods used was poor.

Adjuvant treatment with dabrafenib and trametinib may be more effective than observation or adjuvant treatment with a PD-1 inhibitor in patients with stage IIIA melanoma.

Multiple measures of patient satisfaction and quality of life improved up to 1 year following Mohs micrographic surgery for facial skin cancer.